Inventory reconciliation

Inventory reconciliation is an audit technique that compares a pharmacy's dispensing records to its wholesaler purchase records over a defined lookback period and treats unexplained variance as evidence of billing inaccuracy, controlled substance diversion, or both. PBM auditors use inventory reconciliation in opioid and specialty audits; DEA inspectors use it in controlled substance audits; OIG investigators use it in fraud referrals. Legitimate variance explanations include manufacturer samples, returns, shrinkage, wholesale credits, and prescribed-but-undispensed claims.

How inventory reconciliation works

The auditor requests the pharmacy's wholesaler invoices and 222 forms (for controlled substances) for the lookback window, then compares those purchase records to the dispensing records on file for the same period and the same drug. The arithmetic is simple: beginning inventory plus purchases minus dispensings should equal ending inventory, within the variance the pharmacy can document. Variance is the dispensing records showing fewer units dispensed than the purchase records would predict, or the reverse.

Negative variance (pharmacy purchased more than it dispensed) raises the question of where the excess went. Positive variance (pharmacy dispensed more than it purchased) raises the question of whether claims were billed without a corresponding dispensing. Each variance pattern carries a different defense theory. The auditor's threshold for finding the variance "unexplained" is the pharmacy's record-keeping rigor: documented samples, documented returns, documented shrinkage, and contemporaneous controlled substance logs.

When inventory reconciliation applies

Inventory reconciliation applies in any audit where the auditor has the right to access wholesaler purchase records or the pharmacy's controlled substance logs. PBM provider manuals typically authorize wholesaler verification as part of the audit cooperation duty. DEA inspectors compel inventory reconciliation under 21 CFR Part 1304 (controlled substance recordkeeping). State boards of pharmacy access inventory records under state pharmacy practice acts. The technique is most often applied to high-value or controlled drug classes: opioids, specialty drugs, GLP-1s, and oncology preparations.

The pharmacy's exposure under inventory reconciliation

The exposure is severe because variance findings often translate directly into recoupment (for billing audits) or DEA show-cause proceedings (for controlled substance audits). For controlled substances, unexplained variance can support a DEA Order to Show Cause leading to revocation of the DEA registration. For specialty drugs, variance supports a False Claims Act referral if the auditor concludes claims were billed without dispensing. The defense framework focuses on reconstructing the contemporaneous record: locating sample documentation, return credits, recall documentation, and corrected dispensings that explain the variance the auditor flagged.

Related terms

• PBM audit The audit framework where inventory reconciliation is most commonly used as a finding-generation technique.
• Extrapolation The statistical technique often applied to variance findings to extend the dollar exposure across the lookback.
• Recoupment The dollar demand that follows when variance findings translate into billing recoupment.
• Provider manual The PBM document that authorizes wholesaler verification as part of audit cooperation.

See also

• Practice area
  PBM Audit Defense

  The full PBM audit defense framework, including variance defense and the documentation reconstruction process.

• Practice area
  DEA Defense

  DEA inspection defense for controlled substance inventory reconciliation findings and the show-cause posture.